Clinical trials
Breast clinical trials
Below are recruiting breast clinical trials, each written for real people, not researchers. We’re tracking 2,691 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07527039RecruitingPhase 4
Nerve Block for Pain Relief During Breast Reduction Surgery
This study tests a special numbing technique (pectoral block) to help control pain after breast reduction surgery in women with very large breasts causing symptoms like neck, shoulder, or back pain. The goal is to see if this nerve block reduces pain better than standard pain control methods.
Roanoke, VirginiaAges 18–75 - NCT06754059Recruiting
Pyrotinib with trastuzumab for HER2-positive breast cancer maintenance
This trial tests a combination of two targeted drugs (pyrotinib and trastuzumab) as maintenance therapy to keep HER2-positive breast cancer that has spread under control. It is for women who have already received some first-line treatment and are stable enough to continue therapy.
Fuzhou, FujianAges 18–70 - NCT06706570Recruiting
PIK3CA gene testing for breast cancer
This trial tests for a specific gene change (PIK3CA mutation) in your breast cancer cells. The results will help doctors decide if a targeted treatment is right for you. It's for people with hormone-receptor-positive, HER2-negative breast cancer that has spread and not yet been treated in that setting.
Milan, MIAges 18 years+ - NCT06748677Recruiting
Nipple-sparing mastectomy with robotic help and implant reconstruction
This trial tests a newer, less invasive way to remove breast tissue while keeping the nipple and skin, using robotic or endoscopic tools. It then rebuilds the breast with an implant wrapped in a non-biological mesh. The goal is to see how well patients recover and how they feel about the results.
Beijing, Beijing MunicipalityAges Any age - NCT07116161Recruiting
Exercise and counseling for fatigue in female breast cancer patients
This trial tests if combining exercise with cognitive behavioral therapy (counseling) can help reduce fatigue in women with breast cancer. You may be able to join if you have completed your initial treatments and still feel tired.
SingaporeAges 21 years+ - NCT07592793Enrolling by invitation
Community Health Worker Perspectives on New Programs
This study asks community health center workers and partner staff about their experiences implementing a new health program. Your feedback helps researchers understand what works and what challenges exist in delivering care in community settings.
Boston, MassachusettsAges 18 years+ - NCT06042803Recruiting
Study on medicine levels in breastmilk
This study looks at how medicines pass into breastmilk. It helps understand the safety of medications while breastfeeding. If you take medicine and breastfeed, this study may be an option for you.
Leuven, Vlaams-BrabantAges 18 years+ - NCT07171658Recruiting
Cervical cancer screening for women getting breast cancer letters
This trial tests if inviting women for cervical cancer screening along with their breast cancer screening letters helps more people get tested. You might be eligible if you haven't had a cervical cancer screening in the last three years.
Geneva, Canton of GenevaAges 50–74 - NCT06523283Recruiting
Nature images with music for first-time breastfeeding mothers
This study tests whether watching nature images with calming music helps first-time mothers feel more satisfied with breastfeeding and more bonded with their baby. If you are a healthy first-time mom who gave birth at full term and can breastfeed, this may help you feel more relaxed and connected.
AdıyamanAges 18 years+ - NCT07560553Recruiting
Teaching Mothers How to Breastfeed Successfully
This study tests whether special breastfeeding education classes help pregnant women prepare to breastfeed their babies. Researchers want to see if learning from healthcare providers before birth makes breastfeeding easier and more successful.
Loma Linda, CaliforniaAges 18–45 - NCT06086132Recruiting
Preventing heart damage from cancer treatment
This trial tracks how cancer treatments affect the heart. It may help doctors find ways to prevent heart problems during your treatment.
BolognaAges 18 years+ - NCT07586215Recruiting
HER2-targeted PET imaging to predict treatment response in advanced breast cancer
This trial tests whether a special type of PET scan can predict how well a targeted cancer drug (T-DXd) will work for patients with advanced breast cancer that has specific HER2 markers. The goal is to help doctors personalize treatment decisions based on imaging results.
ShanghaiAges 18 years+ - NCT07071896Recruiting
Video exercise program for breast cancer survivors
This study tests a video-based exercise program for people who recently had breast cancer surgery. It aims to help with recovery by providing guided exercises you can do at home.
San Diego, CaliforniaAges 18 years+ - NCT07492160RecruitingPhase 2
Cabergoline for Breast Symptoms After Pregnancy Loss
This study tests whether a medication called cabergoline can help stop milk production and reduce breast discomfort after a pregnancy loss or abortion.
Brooklyn, New YorkAges 18 years+ - NCT06923527RecruitingPhase 2
Testing ctDNA to start elacestrant in early breast cancer
This trial tests whether the drug elacestrant can help prevent recurrence in people with a type of breast cancer (ER+/HER2-) who have finished hormone therapy and have signs of cancer DNA in their blood (ctDNA positive) but no visible spread on scans.
New Haven, ConnecticutAges 18 years+ - NCT06966141Recruiting
Real-World Study of Sacituzumab Govitecan for Breast Cancer
This study looks at how well the drug Sacituzumab Govitecan works in real-life settings for people with certain types of advanced breast cancer that have not responded to prior treatments.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07706127Recruiting
Texting support for Latina breast cancer patients on hormone therapy
This study tests if a text message program can help Latina breast cancer patients remember to take their hormone therapy pills. It also looks at how non-medical challenges (like money or housing issues) affect medication taking.
San Antonio, TexasAges 18 years+ - NCT06958627RecruitingPhase 2/Phase 3
Smart phone app vs standard care for breast cancer treatment
This trial tests whether a smartphone-based patient management program helps women with HER2-positive breast cancer take their medication (pyrotinib) more consistently compared to usual care. It may be a good fit if you are starting or continuing pyrotinib treatment.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06607757RecruitingPhase 2
Capivasertib plus fulvestrant for high-risk lobular breast cancer
This trial tests adding capivasertib to fulvestrant for women with a certain type of breast cancer (invasive lobular carcinoma) that is hormone-receptor positive and has a high risk of coming back. The treatment is given before surgery to see if it works better than fulvestrant alone.
AugsburgAges 18 years+ - NCT07496307Recruiting
Breastfeeding education for babies refusing the breast
This study tests if structured breastfeeding education helps mothers with infants 1-6 months old who have been refusing the breast for 3-30 days. It aims to improve breastfeeding success and reduce stress.
Kars, KarsAges 18–45 - NCT07460297Enrolling by invitation
Antibiotic and iodine for infection prevention in breast reconstruction
This trial tests if a combination of a pseudomonas bacteria injection and an iodine solution can help prevent infections in women having immediate breast reconstruction with implants after mastectomy or breast-conserving surgery.
Shenyang, LiaoningAges 18 years+ - NCT06994507RecruitingPhase 3
GM1 to prevent nerve damage from breast cancer chemo
This trial tests whether a drug called GM1 can prevent nerve damage (numbness, tingling, or pain in hands/feet) caused by a common chemotherapy drug used for breast cancer. If you are starting chemotherapy with nab-paclitaxel, this study may help protect your nerves.
BeijingAges 18–75 - NCT07708571Recruiting
Coaching program for women on ribociclib and aromatase inhibitor
This study tests whether a coaching program based on personality types helps women with early-stage hormone receptor-positive, HER2-negative breast cancer stick to their treatment plan. Participants must be taking ribociclib (Kisqali) and an aromatase inhibitor, and their cancer must not have spread to other organs.
Augsburg, BavariaAges 18 years+ - NCT07607366Recruiting
Negative Pressure Bandaging After Breast Removal Surgery
This trial tests a special bandage that uses gentle suction to help wounds heal better after breast cancer surgery. Researchers want to see if this type of bandaging reduces complications like fluid buildup and improves healing.
FalunAges 18 years+
Hear when a new Breast trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast?
- Yes. Clin2 currently lists 2,691 recruiting breast studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.